Ruoning Wang
- Nationwide Children's Hospital · Pediatrics (investigator's affiliation)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #12,540
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11203585Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1.6M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#12,540
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Ruoning Wang as a PI. Multi-PI records show the full award amount for context.
- 1R01CA299046-01A1R01Contact PIGenetically and metabolically defining high-risk neuroblastoma to exploit effective therapeutic strategiesNationwide Children's Hospital · Pediatrics (investigator's affiliation)$608.6Kaward amount
- 5R01AI175004-04R01Contact PIDecipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseasesNationwide Children's Hospital · Pediatrics (investigator's affiliation)$498.6Kaward amount
- 2R37AI114581-11A1R37Contact PITargeting purine catabolism and signaling in T cell autoimmunityNationwide Children's Hospital · Pediatrics (investigator's affiliation)$490.2Kaward amount
Award organization
Organizations that administered FY2026 awards listing Ruoning Wang as a PI.
FY2026 award administered by Nationwide Children's Hospital (OH).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNationwide Children's Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder